Study of Late Fetal Loss in Poitou-Charentes. GYNE-COVID

Analysis Laboratories of the Poitiers CHU Clinical Trial

Official title: Study of Late Fetal Loss in Poitou-Charentes. GYNE-COVID

Status Completed

Clinical Trial Summary

Maternal-fetal transmission in the second or third trimester of pregnancy of the SARS-COV-2 virus could explain some late fetal losses.

Finding a cause in the context of fetal loss is essential for parents and caregivers. It helps to understand the history of the disease, to address the possible risk of a recurrence and to plan for future pregnancies.

If the maternal-fetal transmission of COVID 19 is confirmed and that it is responsible for obstetric complications, a preventive action could be proposed to the patients by the preconception vaccination.

The investigators are seeking to clarify the frequency of this transmission is information awaited by caregivers, women, couples in particular when the latter are in distress from late fetal loss.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Analysis Laboratories of the Poitiers CHU
• Identification of the Mother or Fetus Contamination by SARS Cov-2
• Research the Presence of Viruses at Different Sites of the Mother and the Fetus or Father
• The Survey Builds on a Network Work Already Organized Around the CPDPN of Poitou-Charentes

• NCT number: NCT04387253
• Study type: Interventional
• Source: Poitiers University Hospital
• Status: Completed
• Phase: N/A
• Start date: May 23, 2020
• Completion date: June 17, 2022